Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOSE MENDOZA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1982648036
CMS profile
135536
Location
CLINTON, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$14,216.68

127 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $8,945.00 5
Food and Beverage $3,072.98 112
Travel and Lodging $2,091.18 9
Education $107.52 1

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $7,456.24 16
BeiGene USA, Inc. $1,968.16 2
PFIZER INC. $1,813.81 11
Daiichi Sankyo Inc. $604.99 4
Novartis Pharmaceuticals Corporation $234.15 8
Merck Sharp & Dohme LLC $189.77 8
Lilly USA, LLC $169.51 3
ABBVIE INC. $157.24 6
E.R. Squibb & Sons, L.L.C. $147.23 7
Genentech USA, Inc. $106.11 5
Janssen Biotech, Inc. $99.45 4
Takeda Pharmaceuticals U.S.A., Inc. $96.65 3
GlaxoSmithKline, LLC. $90.93 4
Eisai Inc. $88.37 4
Gilead Sciences, Inc. $72.89 3
Regeneron Healthcare Solutions, Inc. $68.03 2
PUMA BIOTECHNOLOGY, INC. $56.17 3
TerSera Therapeutics LLC $54.88 2
Bayer Healthcare Pharmaceuticals Inc. $50.28 2
Tempus AI, Inc $49.05 2
Celgene Corporation $45.43 2
Mirati Therapeutics, Inc. $43.38 2
Acrotech Biopharma Inc. $36.81 2
GENZYME CORPORATION $35.96 1
Karyopharm Therapeutics Inc. $33.41 1
Alexion Pharmaceuticals, Inc. $31.37 1
Agios Pharmaceuticals, Inc. $30.41 1
Pharmacosmos Therapeutics Inc. $29.88 1
Astellas Pharma US Inc $28.95 1
Ipsen Biopharmaceuticals, Inc $25.99 1
Incyte Corporation $24.92 1
ARRAY BIOPHARMA INC $24.41 1
Biocon Biologics Inc $23.27 1
Kite Pharma, Inc. $23.27 1
SpringWorks Therapeutics, Inc. $21.98 1
Coherus Biosciences Inc. $20.06 1
Amgen Inc. $19.91 1
TAIHO ONCOLOGY, INC. $19.90 1
Celltrion USA Inc. $19.73 1
EMD Serono, Inc. $19.53 1
Exelixis Inc. $19.30 1
ADC Therapeutics America, Inc. $19.24 1
Alnylam Pharmaceuticals Inc. $17.43 1
Myriad Genetic Laboratories, Inc. $14.51 1
SERVIER PHARMACEUTICALS LLC $13.72 1

Page 3 of 3; records 101–127 of 127 matching records. This page contains 27 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOSE MENDOZA

NPI 1982648036 · CMS profile ID 135536

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

CLINTON, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–127 of 127 matching records. This page contains 27 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1982648036?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOSE MENDOZA, NPI 1982648036, CMS profile ID 135536. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–127 of 127 matching records. This page contains 27 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1982648036?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). JOSE MENDOZA, NPI 1982648036, CMS profile ID 135536. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–127 of 127 matching records. This page contains 27 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1982648036?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
JOSE MENDOZA, NPI 1982648036, CMS profile ID 135536, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–127 of 127 matching records. This page contains 27 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1982648036?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

127 matching records · $14,216.68 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 127 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–127 of 127.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Biocon Biologics Inc $23.2702/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154783960 CMS
Genentech USA, Inc. $16.9902/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133039213 CMS
AstraZeneca Pharmaceuticals LP $4.9102/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104399283 CMS
AstraZeneca Pharmaceuticals LP $24.6402/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105525649 CMS
Eisai Inc. $21.8602/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110755238 CMS
PUMA BIOTECHNOLOGY, INC. $20.2502/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1113855431 CMS
Myriad Genetic Laboratories, Inc. $14.5102/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152536245 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.1902/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144963008 CMS
TerSera Therapeutics LLC $27.9202/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144715981 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.0202/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086250482 CMS
PFIZER INC. $9.0002/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131910762 CMS
Novartis Pharmaceuticals Corporation $34.3302/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087059520 CMS
Astellas Pharma US Inc $28.9502/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139292644 CMS
Novartis Pharmaceuticals Corporation $17.2702/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087059494 CMS
E.R. Squibb & Sons, L.L.C. $3.3902/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101416603 CMS
E.R. Squibb & Sons, L.L.C. $20.6802/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101416605 CMS
Mirati Therapeutics, Inc. $23.1302/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117168338 CMS
Celltrion USA Inc. $19.7302/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1075855249 CMS
GlaxoSmithKline, LLC. $17.0501/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115839704 CMS
PFIZER INC. $21.6601/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131575420 CMS
Merck Sharp & Dohme LLC $26.0601/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141668190 CMS
AstraZeneca Pharmaceuticals LP $1,110.0001/09/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105400727 CMS
EMD Serono, Inc. $19.5301/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120224487 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.0601/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144963006 CMS
GlaxoSmithKline, LLC. $18.9201/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116736518 CMS
SpringWorks Therapeutics, Inc. $21.9801/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1085806395 CMS
Tempus AI, Inc $29.6201/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150169796 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,680.65 103
PY2020 $1,462.39 21
PY2021 $156.68 8
PY2022 $5,092.48 110
PY2023 $3,404.82 146
PY2024 $14,216.68 127
PY2025 $8,695.47 119

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $134,544.53 7
PY2024 Principal investigator $21,392.23 4
PY2023 Principal investigator $6,988.25 4
PY2022 Principal investigator $26,548.00 3
PY2021 Recipient $38.20 1
PY2021 Principal investigator $93,098.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $5,000.00 12/31/2025 Non-covered Recipient Entity
MARYLAND ONCOLOGY HEMATOLOGY COLUMBIA
A Phase III, Randomised, Open-Label, Multicentre Study of Datopotamab Deruxtecan or Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung17) No dispute reported 06/30/2026 1185540627
Principal investigator 1 Celgene Corporation $20,714.00 10/15/2025 Non-covered Recipient Entity
Maryland Oncology Hematology, Pa
A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy After Autologous Stem Cell Transplantation (ASCT) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) (EXCALIBER-Maintenance) No dispute reported 06/30/2026 1222304483
Principal investigator 1 Celgene Corporation $3,272.00 05/12/2025 Non-covered Recipient Entity
Us Oncology Research Llc
A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM) (Excaliber-Maintenance) No dispute reported 06/30/2026 1222307215
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $28,865.00 04/15/2025 Non-covered Recipient Entity
Maryland Oncology Hematology, Pa
A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM) (Excaliber-Maintenance) No dispute reported 06/30/2026 1235996091
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $7,098.53 02/25/2025 Non-covered Recipient Entity
Maryland Oncology Hematology Clinton
A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM) (Excaliber-Maintenance) No dispute reported 06/30/2026 1235996101
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $935.00 01/15/2025 Non-covered Recipient Entity
Maryland Oncology Hematology, Pa
A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM) (Excaliber-Maintenance) No dispute reported 06/30/2026 1235996093
Principal investigator 1 Celgene Corporation $68,660.00 01/08/2025 Non-covered Recipient Entity
Us Oncology Research
A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM) (Excaliber-Maintenance) No dispute reported 06/30/2026 1222306867